Achilles Therapeutics Plc
(NASDAQ) ACHL
Achilles Therapeutics Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$67.03M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ACHL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Achilles Therapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
215
CEO
Iraj Ali, PhD
Website
www.achillestx.comHeadquarters
London, W6 8PW, GB
ACHL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-41%
Return on Capital
-52%
Return on Assets
-43%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$4.73M
Operating Income
$75.25M
EBITDA
$70.44M
Operating Cash Flow
$48.45M
Capital Expenditure
$1.10M
Free Cash Flow
$49.55M
Cash & ST Invst.
$131.54M
Total Debt
$4.62M
Achilles Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
204
N/A
Net Income
$19.59M
-17.5%
EBITDA
$20.42M
-14.1%
Quarterly Fundamentals
Net Cash
$82.43M
-37.9%
Accounts Receivable
$21.79M
+127.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$3.62M
-21.6%
Return on Assets
-43.15%
N/A
Return on Invested Capital
-52.09%
N/A
Free Cash Flow
$17.34K
+3.4%
Operating Cash Flow
$17.31K
+0.6%